BioCentury | Apr 10, 2019
Distillery Therapeutics
Antibody-drug conjugate targeting ALK could treat neuroblastoma
...TARGET/MARKER/PATHWAY: Anaplastic lymphoma kinase (ALK) LICENSING STATUS: Patented; licensed to Celldex Therapeutics Inc. PUBLICATION DETAILS: Sano...